Breaking News Instant updates and real-time market news.

CWBHF

Charlotte's Web

$0.00

(0.00%)

08:29
12/09/19
12/09
08:29
12/09/19
08:29

Compass Point starts Charlotte's Web at Buy with $12 price target

As previously reported, Compass Point analyst Rommel Dionisio initiated coverage of Charlotte's Web with a Buy rating and $12 price target. A longer than expected delay in the U.S. FDA issuing regulatory guidelines for the introduction of CBD-infused edibles and beverages has pressured shares, but he sees Charlotte's Web being the best positioned company to benefit from what should be significant growth in the CBD industry for many years to come given position as a pure play with the number one brand of cannabidiol infused products in the U.S.

CWBHF Charlotte's Web
$0.00

(0.00%)

09/25/19
PIPR
09/25/19
NO CHANGE
PIPR
CV Sciences, Charlotte's Web offer most upside on CBD catalysts, says Piper
FDA regulation of cannabidiol products is still evolving, adding uncertainty now, and limiting the scope of federally legal products, Piper Jaffray analyst Michael Lavery tells investors in a research note. The analyst believes an FDA framework for a broader set of permissible products is a "significant upcoming catalyst" for CBD companies, as all retailers could stock a wider selection of higher velocity product forms. Further, he expects steps in the process along the way could also be "smaller catalysts in the meantime," potentially including an FDA update this fall. Owning CV Sciences (CVSI) and Charlotte's Web (CWBHF) ahead of this regulatory clarity offers the most upside, Lavery tells investors in a research note. The analyst also expect both companies to pursue up-listing to the Nasadq or New York Stock Exchange, which he sees as a positive catalyst.
11/07/19
CANT
11/07/19
INITIATION
Target $14.5
CANT
Neutral
Charlotte's Web initiated with a Neutral at Cantor Fitzgerald
Cantor Fitzgerald analyst Pablo Zuanic initiated coverage of Charlotte's Web with a Neutral rating and $14.50 price target.
11/07/19
CANT
11/07/19
INITIATION
CANT
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
Cantor Fitzgerald analyst Pablo Zuanic initiated CV Sciences (CVSI) with an Overweight rating, price target of $4.20 along with Charlotte's Web (CWBHF) and cbdMD (YCBD) at Neutral with respective price targets of $14.50 and $3.40 as part of his broader sector note on Consumer CBD. The analyst says the industry has risen 6-times in two years, reaching $4B in retail sales, and may reach as high as $25B over the next 5 years. Zuanic contends that while it is currently fragmented, the greater adoption of CBD products at big box retailers will likely lead to industry consolidation, helping the more established brands. In the short term however, the analyst still points to the lack of clear FDA guidelines on CBD sales, adding that near term catalysts on the industry are "to the downside".
12/09/19
COMP
12/09/19
INITIATION
Target $15.91
COMP
Buy
Charlotte's Web initiated with a Buy at Compass Point
Compass Point initiated coverage of Charlotte's Web Holdings with a Buy rating and C$15.91 price target.

TODAY'S FREE FLY STORIES

CGEMY

Capgemini

$0.00

(0.00%)

05:51
01/21/20
01/21
05:51
01/21/20
05:51
Initiation
Capgemini initiated  »

Capgemini initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBNY

Signature Bank

$139.09

0.9 (0.65%)

05:51
01/21/20
01/21
05:51
01/21/20
05:51
Earnings
Signature Bank reports Q4 EPS $2.78, consensus $2.70 »

Reports Q4 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

ACN

Accenture

$209.18

0.22 (0.11%)

05:50
01/21/20
01/21
05:50
01/21/20
05:50
Initiation
Accenture initiated  »

Accenture initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 10

    Feb

  • 19

    Mar

RELX

Relx

$26.22

0.06 (0.23%)

05:49
01/21/20
01/21
05:49
01/21/20
05:49
Upgrade
Relx rating change  »

Relx upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAL

TAL Education

$54.07

-2 (-3.57%)

05:48
01/21/20
01/21
05:48
01/21/20
05:48
Hot Stocks
TAL Education announces changes to board »

TAL Education announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

TAL

TAL Education

$54.07

-2 (-3.57%)

05:46
01/21/20
01/21
05:46
01/21/20
05:46
Earnings
TAL Education sees Q4 revenue $959.1M-$980.9M, consensus $1.01B »

If not taking into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

BK

BNY Mellon

$46.18

-0.56 (-1.20%)

05:46
01/21/20
01/21
05:46
01/21/20
05:46
Upgrade
BNY Mellon rating change  »

BNY Mellon upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

TAL

TAL Education

$54.07

-2 (-3.57%)

05:44
01/21/20
01/21
05:44
01/21/20
05:44
Earnings
TAL Education reports Q3 EPS 9c, consensus 9c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

ITRM

Iterum Therapeutics

$3.29

-1.21 (-26.89%)

05:44
01/21/20
01/21
05:44
01/21/20
05:44
Downgrade
Iterum Therapeutics rating change  »

Iterum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDE

Coeur Mining

$5.86

-1.17 (-16.64%)

05:41
01/21/20
01/21
05:41
01/21/20
05:41
Downgrade
Coeur Mining rating change  »

Coeur Mining downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

LGF.B

Lionsgate

$10.32

-0.305 (-2.87%)

05:39
01/21/20
01/21
05:39
01/21/20
05:39
Downgrade
Lionsgate rating change  »

Lionsgate downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

USB

U.S. Bancorp

$55.33

0.14 (0.25%)

05:36
01/21/20
01/21
05:36
01/21/20
05:36
Downgrade
U.S. Bancorp rating change  »

U.S. Bancorp downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 15

    Apr

CHGG

Chegg

$43.36

0.64 (1.50%)

05:34
01/21/20
01/21
05:34
01/21/20
05:34
Recommendations
Chegg analyst commentary  »

Chegg price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

  • 19

    Feb

ROKU

Roku

$130.35

-0.76 (-0.58%)

05:33
01/21/20
01/21
05:33
01/21/20
05:33
Hot Stocks
Roku announces arrival in Brazil through partnership with AOC »

Roku announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

RNR

RenaissanceRe

$193.19

0.235 (0.12%)

05:32
01/21/20
01/21
05:32
01/21/20
05:32
Initiation
RenaissanceRe initiated  »

RenaissanceRe initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 26

    Feb

RE

Everest Re

$279.96

2.455 (0.88%)

05:31
01/21/20
01/21
05:31
01/21/20
05:31
Initiation
Everest Re initiated  »

Everest Re initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

COST

Costco

$304.68

1.83 (0.60%)

05:31
01/21/20
01/21
05:31
01/21/20
05:31
Upgrade
Costco rating change  »

Costco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Mar

HIG

Hartford Financial

$61.20

0.925 (1.53%)

05:30
01/21/20
01/21
05:30
01/21/20
05:30
Initiation
Hartford Financial initiated  »

Hartford Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

UBS

UBS

$13.13

-0.06 (-0.45%)

05:29
01/21/20
01/21
05:29
01/21/20
05:29
Hot Stocks
UBS agrees to sell majority stake in UBS Fondcenter to Clearstream »

UBS Group AG and UBS AG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

AIG

AIG

$52.88

0.52 (0.99%)

05:29
01/21/20
01/21
05:29
01/21/20
05:29
Initiation
AIG initiated  »

AIG initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$140.72

1.85 (1.33%)

05:28
01/21/20
01/21
05:28
01/21/20
05:28
Initiation
Travelers initiated  »

Travelers initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CB

Chubb

$153.67

1 (0.66%)

05:28
01/21/20
01/21
05:28
01/21/20
05:28
Initiation
Chubb initiated  »

Chubb initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

PGR

Progressive

$76.29

0.85 (1.13%)

05:27
01/21/20
01/21
05:27
01/21/20
05:27
Initiation
Progressive initiated  »

Progressive initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALL

Allstate

$117.54

1.39 (1.20%)

05:26
01/21/20
01/21
05:26
01/21/20
05:26
Initiation
Allstate initiated  »

Allstate initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 26

    Feb

  • 13

    Mar

UBS

UBS

$13.13

-0.06 (-0.45%)

05:26
01/21/20
01/21
05:26
01/21/20
05:26
Hot Stocks
UBS targeting RoCET1 of 12%-15% om 2020-2022 »

UBS provided the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.